Antigen Skin Test Market Report to 2031

By Type Bacterial Infection (Tuberculin Test, Lepromin Test, Frei’s, Others), Fungal Infection (Candida Test, Trichophyton, Coccidioidin Test, Histoplasmin Test) Parasitic Infection (Leishmanin Test (Montenegro Test), Onchocerciasis Skin Test), By End User Hospitals, Ambulatory Surgical Centers, Clinics) Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

PAGES: 271

PRODUCT CODE: PHA1044

SUBMARKET: Diagnostics

DOWNLOAD FREE SAMPLE

Licence

Clear

DOWNLOAD FREE SAMPLE

SKU: PHA1044 Categories: Diagnostics, Pharma Tags: PHA0730, PHA1044, PHA1135, PHA1207

Global Antigen Skin Test Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Global Antigen Skin Test market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.

Discover how to stay ahead
Our Global Antigen Skin Test report provides tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antigen Skin Test Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.

Global Antigen Skin Test Market by Type
• Bacterial infection
o Tuberculin Test
o Lepromin Test
o Frei’s
o Others
• Fungal Infection
o Candida test
o Trichophyton
o Coccidioidin test
o Histoplasmin test
• Parasitic Infection
o Leishmanin test (Montenegro test)
o Onchocerciasis Skin test

Global Antigen Skin Test Market by End User
• Hospitals
• Ambulatory Surgical Centers
• Clinics

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Japan
o Rest of Asia Pacific
• Latin America
o Rest of Latin America
• Middle East and Africa
o Rest of Middle East and Africa

The report also includes profiles and for some of the leading companies in the Global Antigen Skin Test Market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall world revenue for Global Antigen Skin Test Market with forecasts for by type, by end user type each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Global Antigen Skin Test Market report helps you
In summary, our 270+ page report provides you with the following knowledge:

• Revenue forecasts to 2031 for Global Antigen Skin Test Market, with forecasts by type, and by end user each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2031 for 5 regional and 20 key national markets – See forecasts for the Global Antigen Skin Test market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Rest of Asia Pacific, Latin America and Middle East and Africa among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for Global Antigen Skin Test of the major companies involved in the Antigen Skin Test Market. Some of the company’s profiled in this report include-
• Becton, Dickinson and Company (BD),
• Coris Bioconcept
• Nielsen BioSciences Inc.
• Physicians Total Care Inc.
• Sanofi Pasteur Limited
• Allermed Laboratories, Inc
• Par Pharmaceuticals
• Era Biology Co. Ltd
• ELITech Group
• QIAGEN
• Creative Diagnostic
• Altas Medical

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

With Information found nowhere else
our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Global Antigen Skin Test Market and leading companies. You will find data, trends, and predictions.

Get our report today Antigen Skin Test Market Report to 2031: By Type Bacterial Infection (Tuberculin Test, Lepromin Test, Frei’s, Others), Fungal Infection (Candida Test, Trichophyton, Coccidioidin Test, Histoplasmin Test) Parasitic Infection (Leishmanin Test (Montenegro Test), Onchocerciasis Skin Test), By End User Hospitals, Ambulatory Surgical Centers, Clinics) Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Global Antigen Skin Test Market
2.1. Antigen Skin Test Market Definition
2.2. By Type Submarkets Definitions
2.3. By End User Submarkets Definitions
3. Global Antigen Skin Test Market Overview
3.1. Global Antigen Skin Test Market Size and Forecast by Region
3.2. Global Antigen Skin Test Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Chronic Allergic Skin Disorders
3.3.1.2. Increasing Health Concerns Among Population.
3.3.1.3. Growing Incidences of Fungal & Bacterial Infection.
3.3.2. Market Restraints/Challenges
3.3.2.1. Adverse Reaction Associated with Antigens, Limits the Growth of the Market.
3.3.3. Opportunities
3.3.3.1. Significant Investments in R&D for Development of Advanced Tests
3.3.3.2. Increasing Demand for Antigen Skin Test
3.3.3.3. Rising Need for Simple, Specific, and Cost-Effective Tests.
3.3.4. Porter’s Five Forces Analysis
3.3.4.1. Competitive Rivalry
3.3.4.2. Supplier Power
3.3.4.3. Buyer Power
3.3.4.4. Threat of Substitution
3.3.4.5. Threat of New Entry
4. Global Antigen Skin Test Market Analysis and Forecast 2021-2031, By Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.2. Bacterial Infection
4.2.1.1. Tuberculin Test
4.2.1.2. Lepromin Test
4.2.1.3. Frei’s
4.2.1.4. Others
4.2.2. Fungal Infections
4.2.2.1. Candida test
4.2.2.2. Trichophyton
4.2.2.3. Coccidioidin test
4.2.2.4. Histoplasmin test
4.2.3. Parasitic Infection
4.2.3.1. Leishmanin test (Montenegro test)
4.2.3.2. Onchocerciasis Skin test

5. Global Antigen Skin Test Market Analysis and Forecast, 2021-2031 By End User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Hospitals
5.1.2. Ambulatory Surgical Centers
5.1.3. Clinics
6. North America Antigen Skin Test Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Antigen Skin Test Market Size and Forecast By Type
6.3. North America Antigen Skin Test Market Size and Forecast By End User
6.4. U.S. Antigen Skin Test Market
6.5. Canada Antigen Skin Test Market
7. Europe Antigen Skin Test Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Antigen Skin Test Market Size and Forecast By Type
7.3. Europe Antigen Skin Test Market Size and Forecast By End User
7.4. UK Antigen Skin Test Market
7.5. Germany Antigen Skin Test Market
7.6. France Antigen Skin Test Market
7.7. Rest of Europe Antigen Skin Test Market
8. Asia Pacific Antigen Skin Test Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Antigen Skin Test Market Size and Forecast By Type
8.3. Asia Pacific Antigen Skin Test Market Size and Forecast By End User
8.4. China Antigen Skin Test Market
8.5. India Antigen Skin Test Market
8.6. Japan Antigen Skin Test Market
8.7. Rest of Asia Pacific Antigen Skin Test Market
9. Latin America Antigen Skin Test Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Antigen Skin Test Market Size and Forecast By Type
9.3. Latin America Antigen Skin Test Market Size and Forecast By End User
9.3.1. Brazil Antigen Skin Test Market
9.3.2. Mexico Antigen Skin Test Market
9.3.3. Rest of Latin America Antigen Skin Test Market
10. MEA Antigen Skin Test Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Antigen Skin Test Market Size and Forecast By Type
10.3. MEA Antigen Skin Test Market Size and Forecast By End User
10.4. South Africa Antigen Skin Test Market
10.5. Rest of MEA Antigen Skin Test Market
11. Companies in the Antigen Skin Test Market
11.1. Becton, Dickinson and Company (BD),
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.2.1. Net Revenue
11.1.3. Product Offerings
11.1.4. Recent Initiatives (2017-2020)
11.2. Coris BioConcept,
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance (2015-2020)
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.4. Product Offerings
11.2.5. Recent Initiatives (2017-2020)
11.3. Nielsen BioSciences, Inc.
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance (2015-2020)
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.4. Product Offerings
11.3.5. Recent Initiatives (2017-2020)
11.4. Physicians Total Care Inc.
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance (2015-2020)
11.4.3.1. Net Revenue
11.4.4. Product Offerings
11.4.5. Recent Initiatives (2017-2020)
11.5. Sanofi Pasteur Limited
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance (2015-2020)
11.5.3.1. Net Revenue
11.5.4. Product Offerings
11.5.5. Recent Initiatives (2017-2020)
11.6. Allermed Laboratories, Inc
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance (2015-2020)
11.6.3.1. Net Revenue
11.6.3.2. Geographical Revenue, 2020
11.6.4. Product Offerings
11.6.5. Recent Initiatives (2017-2020)
11.7. Par Pharmaceuticals
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance (2015-2020)
11.7.3.1. Net Revenue
11.7.4. Product Offerings
11.7.5. Recent Initiatives (2017-2020)
11.8. Era Biology Co. Ltd
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance (2015-2020)
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.4. Product Offerings
11.8.5. Recent Initiatives (2017-2020)
11.9. ELITech Group
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance (2015-2020)
11.9.3.1. Net Revenue
11.9.4. Product Offerings
11.9.5. Recent Initiatives (2017-2020)
11.10. QIAGEN
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance (2015-2020)
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.4. Product Offerings
11.10.5. Recent Initiatives (2017-2020)
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form

LIST OF TABLES
Table 1. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 2. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Antigen Skin Test Market Drivers & Restraints 2021
Table 7. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Bacterial infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Bacterial infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Bacterial infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Bacterial infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Bacterial infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Fungal infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 18. Fungal infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Fungal infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Fungal infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Fungal infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Parasitic infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 23. Parasitic infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Parasitic infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Parasitic infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Parasitic infection Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 28. Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Hospital Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Hospital Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Hospital Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Hospital Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Hospital Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Ambulatory Surgical Center Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 38. Ambulatory Surgical Center Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Ambulatory Surgical Center Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Ambulatory Surgical Center Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Ambulatory Surgical Center Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Clinics Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table43. Clinics Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Clinics Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Clinics Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Clinics Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Regional Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48. Regional Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Regional Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Regional Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Regional Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. North America Antigen Skin Test Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. North America Antigen Skin Test Market Forecast By End User 2021-2031(US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table61. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario W)
Table 76. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table81. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table96. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario U)
Table 105. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario W)
Table 106. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR%, CAGR %) (COVID - Scenario W)
Table 111. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Asia Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. Asia Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Asia Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Asia Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Asia Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Asia Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Asia Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Asia Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Asia Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Asia Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L
Table 122. Asia Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. Asia Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Asia Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Asia Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Asia Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. RoAPAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. RoAPAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. RoAPAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. RoAPAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. RoAPAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150 Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152 Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153 Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155 Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164 Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167 Leading 10 Antigen Skin Test Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 168. Becton, Dickinson and Company (BD), Profile 2020 (CEO, HQ, Founded, Website)
Table 169. Becton, Dickinson and Company (BD), Antigen Skin Test Selected Recent Contracts 2020 (Date, Program Type, Details)
Table 170. Coris Bio Concept, Antigen Skin Test Product Offering (Segment, Product Offerings)
Table 171. Coris Bio Concept, Profile 2020 (CEO, HQ, Founded, Website)
Table 172. Coris Bio Concept, Antigen Skin Test Product Offering (Segment, Product Offerings)
Table 173. Nielsen Bio Sciences Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 174. Nielsen Bio Sciences Inc. Antigen Skin Test Selected Recent Contracts 2017-2020 (Date, Program Type, Details)
Table 175. Nielsen Bio Sciences Inc. Antigen Skin Test Product Offering (Segment, Product Offerings)
Table 176. Physicians Total Care Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 177. Physicians Total Care Inc Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 178. Physicians Total Care Inc Antigen Skin Test Product Offering (Segment, Product Offerings)
Table 179. Sanofi Pasteur Limited Profile 2020 (CEO, HQ, Founded, Website)
Table 180. Sanofi Pasteur Limited Antigen Skin Test Product Offering (Segment, Product Offerings)
Table 181. Allermed Laboratories, Inc Profile 2020 (CEO, HQ, Founded, Website)
Table 182. Allermed Laboratories, Inc Antigen Skin Test Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 183 Allermed Laboratories, Inc Antigen Skin Test Product Offering (Segment, Product Offerings)
Table 184. Par Pharmaceuticals, Profile 2020 (CEO, HQ, Founded, Website)
Table 185. Par Pharmaceuticals, Antigen Skin Test Product Offering (Segment, Product Offerings)
Table 186. Era Biology Co. Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 187. Era Biology Co. Ltd Antigen Skin Test Product Offering (Segment, Product Offerings)
Table 188. ELITech Group Profile 2020 (CEO, HQ, Founded, Website)
Table 189. ELITech Group Antigen Skin Test Product Offering (Segment, Product Offerings
Table 190. Other Companies Involved in the Antigen Skin Test Market (Company, Location)

LIST OF FIGURES
Figure 1. Antigen Skin Test Market Overview
Figure 2. Antigen Skin Test Market by Type Overview
Figure 3. Antigen Skin Test Market by End User Overview
Figure 4. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 10. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 11. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 12. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 13. Antigen Skin Test Submarket Forecast By Type 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 14. Antigen Skin Test Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 15. Antigen Skin Test Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 16. Antigen Skin Test Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 17. Antigen Skin Test Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 18. Antigen Skin Test Submarket Forecast By End User 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 19. Regional Antigen Skin Test Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 20. Regional Antigen Skin Test Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 21. Regional Antigen Skin Test Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 22. Regional Antigen Skin Test Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 23. Regional Antigen Skin Test Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 24. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %) (Before COVID)
Figure 25. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 26. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 27. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 28. North America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 29. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %)
Figure 30. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 31. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 32. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 33. North America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 34. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 35. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 36. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 37. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 38. North America Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 39. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 40. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 41. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 42. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 43. US Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 44. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %)
Figure 45. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 46. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 47. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 48. Canada Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 49. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M)
Figure 50. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 51. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 52. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 53. Europe Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 54. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (Before COVID)
Figure 55. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 56. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 57. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 58. Europe Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 59. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 60. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 61. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 62. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 63. Europe Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 64. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 65. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 66. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 67. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 68. UK Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 69. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %)
Figure 70. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 71. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 72. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 73. Germany Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 74. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %)
Figure 75. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 76. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 77. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 78. France Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 79. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 80. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 81. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 82. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 83. Rest of Europe Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 84 Asia-Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (Before COVID)
Figure 85. Asia-Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 86. Asia-Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 87. Asia-Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 88. Asia-Pacific Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 89. Asia-Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 90. Asia-Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 91. Asia-Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 92. Asia-Pacific Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 93. Asia-Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 94. Asia-Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 95. Asia-Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 96. Asia-Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 97. Asia-Pacific Antigen Skin Test Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 98. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %)
Figure 99. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 100. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 101 China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 102. China Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 103. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %)
Figure 104. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 105. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 106. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 107. India Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 108. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 109. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 110. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 111. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 112. Japan Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 113. Rest of APAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 114. Rest of APAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 115 Rest of APAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 116. Rest of APAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 117. Rest of APAC Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 118. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M)
Figure 119. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 120. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 121. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 122. Middle East Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 123. Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M)
Figure 124. Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 125. Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 126. Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 127. Middle East Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 128. Rest of Middle East Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %)
Figure 129. Rest of Middle East Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 130. Rest of Middle East Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 131. Rest of Middle East Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 132. Rest of Middle East Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 133. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M)
Figure 134. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 135. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 136. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 137. Latin America Antigen Skin Test Market Forecast By Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 138. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M)
Figure 139. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 140. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 141. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 142. Latin America Antigen Skin Test Market Forecast By End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 143. Rest of Latin America Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %)
Figure 144. Rest of Latin America Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 145. Rest of Latin America Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 146. Rest of Latin America Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 147. Rest of Latin America Antigen Skin Test Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 148. Porter’s Five Force Analysis

Companies Mentioned
1. Becton, Dickinson and Company (BD)
2. Coris Bioconcept
3. Nielsen BioSciences Inc.
4. Physicians Total Care Inc.
5. Sanofi Pasteur Limited
6. Allermed Laboratories, Inc
7. Par Pharmaceuticals
8. Era Biology Co. Ltd
9. ELITech Group
10. QIAGEN
11. Creative Diagnostic
12. Altas Medical
13. Aenova Holding GmbH

Companies Profiled in the Report
1. Becton, Dickinson and Company (BD),
2. Coris Bioconcept
3. Nielsen BioSciences, Inc.
4. Physicians Total Care Inc.
5. Sanofi Pasteur Limited
6. Allermed Laboratories, Inc
7. Par Pharmaceuticals
8. Era Biology Co. Ltd
9. ELITech Group
10. QIAGEN
11. Creative Diagnostic
12. Altas Medical
13. Aenova Holding GmbH
14. Abbott Laboratories

List of Companies Mentioned in the Report:
1. Becton, Dickinson and Company (BD),
2. Coris Bioconcept
3. Nielsen BioSciences, Inc.
4. Physicians Total Care Inc.
5. Sanofi Pasteur Limited
6. Allermed Laboratories, Inc
7. Par Pharmaceuticals
8. Era Biology Co. Ltd
9. ELITech Group
10. QIAGEN
11. Creative Diagnostic
12. Altas Medical
13. Aenova Holding GmbH

List of Organizations Mentioned in the Report
1. World Health Organization
2. The European Medicines Agency (EMA)
3. UNSF Health
4. National Institute of Allergy and Infectious Diseases (NIAID),
5. American College of Allergy, Asthma & Immunology
6. U.S. Department of Health & Human Services
7. Clinical Microbiology & Infection
8. The American Association for Cancer Research.
9. Organic Process Research & Development
10. The National Cancer Survivorship Resource Center
11. US Food & Drug Administration
12. US National Library of Medicine
13. National Institutes of Health
14. National Association for Biomedical Research
15. Center for Disease Control and Prevention CDC
16. Journal of the American college of Cardiology
17. National Association of Orthopaedic Nurses
18. National Foundation for Infectious Diseases.
19. Clinical Infectious Diseases
20. American Association for Cancer Research.
21. Center for Diseases Dynamics, Economics & Policy (CDDEP)
22. The Global Health Security Agenda (GHSA)